WHO tips need manufacturers to apply a steady threat management system for sterility test isolators, such as typical danger assessments and the development of threat-based mostly Command strategies. Manufacturers wanting to implement these approaches need to present strong validation data to demonstrate their equivalence to pharmacopoeial solutions. Whether it waiting for link from Forum Profiles (6)